Online first
Review paper
Published online: 2024-08-09
Community pharmacists’ role in prevention of breast cancer — is it possible?
DOI: 10.5603/rpor.101992
Abstract
One of the most common cancers in women leading to death is breast cancer. The main reason for poor treatment results in Poland is inadequate response to the population-based early detection screening program for breast cancer. Women tend to ignore the initial symptoms, neglect breast self-examinations, and skip regular screening tests, which are crucial for preventing the disease, which is associated with insufficient education on the topic and the deficiency of visible promotional campaigns aimed at encouraging women to undergo regular preventive examinations. Local pharmacies, which are often visited by patients, are a good place to start working on breast cancer prevention. Pharmacists, as trusted health professionals, play a significant role in educating their patients about breast cancer and encouraging women to perform breast self-examinations and undergo mammograms regularly. The aim of this article is to review studies focusing on promotional campaigns for breast cancer awareness that are currently in place or ready to be implemented in pharmacies in many countries. Additionally, we will focus on how pharmacists can educate patients and encourage them to undergo screening tests to prevent breast cancer. This is such a crucial aspect because prevention of cancer is as important as treatment.
Keywords: community pharmacybreast cancer preventionhealth promotionscreening tests
References
- Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1): 7–33.
- Sun YS, Zhao Z, Yang ZN, et al. Risk Factors and Preventions of Breast Cancer. Int J Biol Sci. 2017; 13(11): 1387–1397.
- Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020; 20(8): 417–436.
- Borowska M, Religioni U, Augustynowicz A. Implementation of a population-based breast cancer prevention program in Poland before, during and after the COVID-19 pandemic. Poland in comparison with other countries. Nowotwory. J Oncol. 2023; 73(3): 122–128.
- Homa M, Ziarko M, Litwiniuk M. Coping with cancer and a history of health-related events. Rep Pract Oncol Radiother. 2023; 28(1): 66–73.
- Ayoub NM, Al-Taani GM, Almomani BA, et al. Knowledge and Practice of Breast Cancer Screening Methods among Female Community Pharmacists in Jordan: A Cross-Sectional Study. Int J Breast Cancer. 2021; 2021: 9292768.
- Załuska-Kusz J, Litwiniuk M. Follow-up after breast cancer treatment. Rep Pract Oncol Radiother. 2022; 27(5): 875–880.
- Hussein H, Abbas E, Keshavarzi S, et al. Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis. Radiology. 2023; 306(3): e221785.
- Drukteinis JS, Mooney BP, Flowers CI, et al. Beyond mammography: new frontiers in breast cancer screening. Am J Med. 2013; 126(6): 472–479.
- Luo C, Wang Le, Zhang Y, et al. Advances in breast cancer screening modalities and status of global screening programs. Chronic Dis Transl Med. 2022; 8(2): 112–123.
- Baek SJ, Ko KH, Jung HK, et al. Comparison of Abbreviated MRI with Mammography and Ultrasound in Women with a Personal History of Breast Cancer. Acad Radiol. 2022; 29 Suppl 1: S19–S25.
- Witowski J, Heacock L, Reig B, et al. Improving breast cancer diagnostics with deep learning for MRI. Sci Transl Med. 2022; 14(664): eabo4802.
- Leithner D, Moy L, Morris EA, et al. Abbreviated MRI of the Breast: Does It Provide Value? J Magn Reson Imaging. 2019; 49(7): e85–e8e100.
- Dembrower K, Crippa A, Colón E, et al. ScreenTrustCAD Trial Consortium. Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study. Lancet Digit Health. 2023; 5(10): e703–e711.
- Rahman WT, Helvie MA. Breast cancer screening in average and high-risk women. Best Pract Res Clin Obstet Gynaecol. 2022; 83: 3–14.
- Tesch ME, Partridge AH. Treatment of Breast Cancer in Young Adults. Am Soc Clin Oncol Educ Book. 2022; 42: 1–12.
- Bastos MC, Almeida AP, Bagnoli F, et al. Early breast cancer: concept and therapeutic review. Rev Assoc Med Bras (1992). 2023; 69(suppl 1): e2023S114.
- Kurniasih DA, Setiawati EP, Pradipta IS, et al. Patients' Perspectives of Interprofessional Collaboration in Breast Cancer Unit. Healthcare (Basel). 2023; 11(3).
- Waszyk-Nowaczyk M, Guzenda W, Kamasa K, et al. Cooperation Between Pharmacists and Physicians - Whether It Was Before and is It Still Ongoing During the Pandemic? J Multidiscip Healthc. 2021; 14: 2101–2110.
- Ilardo ML, Speciale A. The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication. Int J Environ Res Public Health. 2020; 17(2).
- Tanaka K, Hori A, Tachi T, et al. Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer. J Pharm Health Care Sci. 2018; 4: 9.
- Mensah KB, Oosthuizen F, Bangalee V. Cancer health promotion in Ghana: A survey of community pharmacists' perception and barriers. J Oncol Pharm Pract. 2020; 26(6): 1361–1368.
- Taiwo OO, Panas R. Roles of community pharmacists in improving oral health awareness in Plateau State, Northern Nigeria. Int Dent J. 2018; 68(4): 287–294.
- Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother. 2006; 40(7-8): 1400–1406.
- Awad A, Abahussain E. Health promotion and education activities of community pharmacists in Kuwait. Pharm World Sci. 2010; 32(2): 146–153.
- Volmer D, Vendla K, Vetka A, et al. Pharmaceutical care in community pharmacies: practice and research in Estonia. Ann Pharmacother. 2008; 42(7): 1104–1111.
- Buhl C, Olsen NL, Nørgaard LS, et al. Community Pharmacy Staff's Knowledge, Educational Needs, and Barriers Related to Counseling Cancer Patients and Cancer Survivors in Denmark. Int J Environ Res Public Health. 2023; 20(3).
- Sendall MC, Ostermann L, Brown C, et al. Health promotion of bowel cancer and breast cancer screening in community pharmacies: Pharmacists' perceptions of their role, knowledge and confidence. Pharm Pract (Granada). 2018; 16(4): 1275.
- Park K, Hong WH, Kye SuY, et al. Community-based intervention to promote breast cancer awareness and screening: the Korean experience. BMC Public Health. 2011; 11: 468.
- Giles JT, Kennedy DT, Dunn EC, et al. Results of a community pharmacy-based breast cancer risk-assessment and education program. Pharmacotherapy. 2001; 21(2): 243–253.
- Lindsey L, Husband A, Nazar H, et al. Promoting the early detection of cancer: a systematic review of community pharmacy-based education and screening interventions. Cancer Epidemiol. 2015; 39(5): 673–681.
- McGuire TR, Leypoldt M, Narducci WA, et al. Accessing rural populations: role of the community pharmacist in a breast and cervical cancer screening programme. J Eval Clin Pract. 2007; 13(1): 146–149.
- Calis KA, Hutchison LC, Elliott ME, et al. American College of Clinical Pharmacy. Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy. 2004; 24(9): 1241–1294.
- Oqal M, Odeh M, Abudalu R, et al. Assessing the knowledge, attitudes and barriers regarding health promotion of breast cancer among community pharmacists. Future Sci OA. 2022; 8(10): FSO826.
- El Hajj MS, Hamid Y. Breast cancer health promotion in Qatar: a survey of community pharmacists' interests and needs. Int J Clin Pharm. 2013; 35(3): 376–385.
- Ayenew W, Seid AM, Kasahun AE, et al. Assessment of community pharmacy professionals' willingness, involvement, beliefs, and barriers to offer health promotion services: a cross-sectional study. BMC Health Serv Res. 2022; 22(1): 1539.
- Mensah KB, Mensah AB, Yamoah P, et al. Knowledge assessment and barriers to cancer screening among Ghanaian community pharmacists. J Oncol Pharm Pract. 2022; 28(1): 64–73.